{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:55Z","timestamp":1791286975196,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2011.09.114","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T09:20:57Z","timestamp":1339060857000},"page":"4301-4306","source":"Crossref","is-referenced-by-count":254,"title":["Flaviviruses and flavivirus vaccines"],"prefix":"10.1016","volume":"30","author":[{"given":"Franz X.","family":"Heinz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stiasny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.09.114_bib0005","series-title":"Fields virology","first-page":"1153","article-title":"Flaviviruses","author":"Gubler","year":"2007"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0010","series-title":"Virus taxonomy. VIIIth report of the international committee on taxonomy of viruses","first-page":"981","article-title":"Family Flaviviridae","author":"Thiel","year":"2005"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0015","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.114_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrmicro2595","article-title":"Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health","volume":"9","author":"Vasilakis","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.114_bib0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1586\/erv.11.35","article-title":"Emerging vector-borne flavivirus diseases: are vaccines the solution?","volume":"10","author":"Gubler","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2011.09.114_bib0030","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.114_bib0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1473-3099(09)70254-3","article-title":"Progress towards a dengue vaccine","volume":"9","author":"Webster","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"9611","key":"10.1016\/j.vaccine.2011.09.114_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0045","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/651271","article-title":"Japanese encephalitis: new options for active immunization","volume":"50","author":"Halstead","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9627","key":"10.1016\/j.vaccine.2011.09.114_bib0050","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.vaccine.2011.09.114_bib0055","first-page":"241","article-title":"Vaccines against tick-borne encephalitis: WHO position paper","volume":"86","author":"WHO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/521911","article-title":"The continuing spread of West Nile virus in the western hemisphere","volume":"45","author":"Gubler","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3201\/eid1108.050289a","article-title":"Epidemiology and transmission dynamics of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0070","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI21623","article-title":"West Nile virus: a growing concern?","volume":"113","author":"Gould","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0075","unstructured":"CDC. http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/index.htm."},{"key":"10.1016\/j.vaccine.2011.09.114_bib0080","series-title":"Fields virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"issue":"5871","key":"10.1016\/j.vaccine.2011.09.114_bib0085","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.vaccine.2011.09.114_bib0090","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1128\/JVI.01637-09","article-title":"Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion","volume":"83","author":"Yu","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.114_bib0095","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/JVI.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.114_bib0100","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.114_bib0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"5643","key":"10.1016\/j.vaccine.2011.09.114_bib0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"Mukhopadhyay","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.114_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011","journal-title":"Microbes Infect"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2011.09.114_bib0120","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1099\/vir.0.82210-0","article-title":"Flavivirus membrane fusion","volume":"87","author":"Stiasny","year":"2006","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.114_bib0125","doi-asserted-by":"crossref","first-page":"e1000718","DOI":"10.1371\/journal.ppat.1000718","article-title":"Immature dengue virus: a veiled pathogen?","volume":"6","author":"Rodenhuis-Zybert","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6529","key":"10.1016\/j.vaccine.2011.09.114_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2\u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vaccine.2011.09.114_bib0135","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.114_bib0140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/JVI.79.2.1223-1231.2005","article-title":"Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein","volume":"79","author":"Modis","year":"2005","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2011.09.114_bib0145","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.114_bib0150","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational changes of the flavivirus E glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"},{"issue":"23","key":"10.1016\/j.vaccine.2011.09.114_bib0155","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0160","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/JVI.76.8.3784-3790.2002","article-title":"Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH","volume":"76","author":"Stiasny","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.114_bib0165","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1371\/journal.ppat.0030020","article-title":"Characterization of a structural intermediate of flavivirus membrane fusion","volume":"3","author":"Stiasny","year":"2007","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2011.09.114_bib0170","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol Rev"},{"issue":"7059","key":"10.1016\/j.vaccine.2011.09.114_bib0185","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.vaccine.2011.09.114_bib0190","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.00660-09","article-title":"Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E","volume":"83","author":"Kiermayr","year":"2009","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2011.09.114_bib0195","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2011.09.114_bib0200","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step","volume":"83","author":"Vogt","year":"2009","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2011.09.114_bib0205","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1128\/JVI.01420-07","article-title":"Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody","volume":"81","author":"Lai","year":"2007","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.09.114_bib0210","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00291-08","article-title":"Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo","volume":"82","author":"Goncalvez","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.114_bib0215","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virol.2005.04.031","article-title":"Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants","volume":"337","author":"Daffis","year":"2005","journal-title":"Virology"},{"issue":"23","key":"10.1016\/j.vaccine.2011.09.114_bib0220","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1128\/JVI.78.23.12919-12928.2004","article-title":"Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein","volume":"78","author":"Goncalvez","year":"2004","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2011.09.114_bib0225","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"issue":"44","key":"10.1016\/j.vaccine.2011.09.114_bib0230","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.114_bib0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0264-410X(88)90004-7","article-title":"Prospects for a virus non-structural protein as a subunit vaccine","volume":"6","author":"Gibson","year":"1988","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2011.09.114_bib0245","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1128\/JVI.00879-07","article-title":"Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile virus-infected cells","volume":"81","author":"Chung","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.114_bib0250","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.1958.7.561","article-title":"Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses","volume":"7","author":"Clarke","year":"1958","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2011.09.114_bib0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J Gen Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2011.09.114_bib0260","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.114_bib0265","doi-asserted-by":"crossref","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog"},{"issue":"20","key":"10.1016\/j.vaccine.2011.09.114_bib0270","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J"},{"issue":"16","key":"10.1016\/j.vaccine.2011.09.114_bib0275","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine \u2013 how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2011.09.114_bib0285","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2011.09.114_bib0290","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"issue":"9602","key":"10.1016\/j.vaccine.2011.09.114_bib0295","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2011.09.114_bib0300","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO(R), IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2011.09.114_bib0305","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","article-title":"Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study","volume":"27","author":"Schuller","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.114_bib0310","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0315","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0325","series-title":"Vaccines","first-page":"841","article-title":"Tick-borne encephalitis virus vaccines","author":"Barrett","year":"2008"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0330","series-title":"Vaccine for biodefense and emerging infectious diseases","first-page":"713","article-title":"Tick-borne encephalitis","author":"Lehrer","year":"2009"},{"issue":"43","key":"10.1016\/j.vaccine.2011.09.114_bib0335","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0340","series-title":"TBE: new paradigms in a changing vaccination environment (13th ISW-TBE 2011)","article-title":"Tactics and strategy of vaccine prevention of tick-borne encephalitis in the Sverdlovsk region","author":"Romanenko","year":"2011"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0345","series-title":"Frontiers in dengue virus research","first-page":"157","article-title":"Evolutionary dynamics of dengue virus","author":"Bennett","year":"2010"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0350","series-title":"Frontiers in dengue virus research","first-page":"79","article-title":"Host and virus determinants of susceptibility and dengue disease severity","author":"Guzman","year":"2010"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","article-title":"Global spread and persistence of dengue","volume":"62","author":"Kyle","year":"2008","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0360","series-title":"Dengue","first-page":"219","article-title":"Pathogenesis: risk factors for infection","author":"Halstead","year":"2008"},{"issue":"10","key":"10.1016\/j.vaccine.2011.09.114_bib0365","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0370","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/383043","article-title":"Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization","volume":"189","author":"Jessie","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0375","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2009.80.416","article-title":"Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining","volume":"80","author":"Balsitis","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.114_bib0380","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: a reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.114_bib0385","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tim.2011.02.002","article-title":"Partial maturation: an immune-evasion strategy of dengue virus?","volume":"19","author":"Rodenhuis-Zybert","year":"2011","journal-title":"Trends Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.114_bib0390","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.114_bib0395","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.114_bib0400","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.4049\/jimmunol.176.6.3821","article-title":"T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?","volume":"176","author":"Mongkolsapaya","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.114_bib0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.icb.7100008","article-title":"Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF\/DSS)","volume":"85","author":"Pang","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2011.09.114_bib0410","series-title":"Frontiers in dengue virus research","first-page":"221","article-title":"Prospects and challenges for dengue virus vaccine development","author":"Whitehead","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.114_bib0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14760584.3.2.199","article-title":"Recent advancement in flavivirus vaccine development","volume":"3","author":"Chang","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"42","key":"10.1016\/j.vaccine.2011.09.114_bib0425","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.114_bib0430","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T14:58:52Z","timestamp":1594220332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":86,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X11015568"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.114","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}